Loading company…
Phosphoenix develops implantable neurostimulation technology intended to restore functional vision for people with profound blindness.
Phosphoenix is a medical technology spin-off from the Netherlands Institute for Neuroscience. It develops implantable neurostimulation technology that interfaces with the brain’s visual pathway. Founded in 2019, the company is based in Amsterdam, Netherlands. In September 2026, it raised EUR 1.3 million from 819 Capital, BioGeneration Ventures, Innovatiefonds Noord-Holland and ROM InWest to prepare for its first-in-human clinical study and further develop its system.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in